Assembly Biosciences Inc., of South San Francisco, appointed Jason Okazaki chief legal and business officer.

Cytovance Biologics LLC, of Oklahoma City, appointed Jesse McCool CEO.

Immunicum AB, of Stockholm, announced that Peter Suenaert will resume the role of chief medical officer, effective May 1, 2020.

Lumos Pharma Inc., of Austin, Texas, appointed Joseph S. McCracken to its board. CEO Rick Hawkins was named chairman of the board.

Nextcure Inc., of Beltsville, Md., appointed Garry Nicholson to its board.

Rhythm Pharmaceuticals Inc., of Boston, appointed Hunter Smith interim CEO in addition to his role of chief financial officer.

No Comments